Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chile seeks to boost cervical screening uptake

This article was originally published in Clinica

Executive Summary

Chile has renewed calls for women to attend their cervical screening appointment, in a bid to increase uptake rates. 66% of women aged 25-64 years currently take up the three-yearly offer, yet "the ideal rate for reducing cervical cancer-related mortality is 80%", claims the health ministry, estimating that this would save an additional 700 or so lives annually. Cervical cancer is covered by Chile's "guaranteed access to care" (AUGE) programme, which promises specialist care within 30 days of a confirmed diagnosis. Between July 2005 and June 2008, AUGE treated 50,422 cases, according to a government report on the first three years of the programme.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT041807

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel